Metfomin-associated lactic acidosis (MALA) is a rare but life-threatening complication of metformin use. We present a case of MALA with concurrent cardiogenic and vasoplegic shock which was successfully supported by ECPella (concurrent use of VA-ECMO and Impella). Early recognition, aggressive hemodynamic support with ECPella and early hemodialysis can be life-saving. Monitoring of both lactate and SvO2 trends can help understand the response to treatment.
BuseJBWexlerDJTsapasA, et al.2019 update to: management of hyperglycemia in type 2 diabetes, 2018. a consensus report by the american diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care2020; 43(2): 487–493.
2.
VieiraIHBarrosLMBaptistaCF, et al.Recommendations for practical use of metformin, a central pharmacological therapy in type 2 diabetes. Clin Diabetes2022; 40(1): 97–107.
3.
DeFronzoRFlemingGAChenK, et al.Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism2016; 65(2): 20–29.
4.
WangGSHoyteC. Review of Biguanide (Metformin) toxicity. J Intensive Care Med2019; 34(11–12): 863–876.
5.
LuftDDeichselGSchmüllingRM, et al.Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol1983; 80(4): 484–489.
ThammavaranucuptKPhonyangnokBParapiboonW, et al.Metformin-associated lactic acidosis and factors associated with 30-day mortality. PLoS One2022; 17(8): e0273678.
8.
BlumenbergABenabbasRSinertR, et al.Do Patients die with or from metformin-associated lactic acidosis (mala)? systematic review and meta-analysis of pH and Lactate as Predictors of Mortality in MALA. J Med Toxicol2020; 16(2): 222–229.
9.
LalauJDRaceJM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf1999; 20(4): 377–384.
10.
LüsebrinkEBinzenhöferLKellnarA, et al.Venting during venoarterial extracorporeal membrane oxygenation. Clin Res Cardiol2022; 112(4): 464–505.
11.
VallabhajosyulaSO'HoroJCAntharamP, et al.Venoarterial extracorporeal membrane oxygenation with concomitant impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock. ASAIO J2020; 66(5): 497–503.
12.
SchrageBBecherPMBernhardtA, et al.Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter Cohort Study. Circulation2020; 142(22): 2095–2106.
13.
Ives TallmanCZhangYBlackN, et al.Refractory vasodilatory shock secondary to metformin overdose supported with VA ECMO. Toxicol Rep2021; 9: 64–67.
14.
ChenTZhuCLiuB. Extracorporeal membrane oxygenation with continuous renal replacement therapy to treat metformin-associated lactic acidosis: A case report. Medicine (Baltimore)2020; 99(26): e20990.
15.
RadziukJZhangZWiernspergerN, et al.Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver. Diabetes1997; 46(9): 1406–1413.
16.
ProttiARussoRTagliabueP, et al.Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication. Crit Care2010; 14(1): R22.
17.
DavisBJXieZViolletB, et al.Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes2006; 55(2): 496–505.
18.
MayerBBrunnerFSchmidtK. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol1993; 45(2): 367–374.
19.
SabatiniSKurtzmanNA. Bicarbonate therapy in severe metabolic acidosis. J Am Soc Nephrol2009; 20(4): 692–695.
20.
JungBRimmeleTLe GoffC, et al.Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care2011; 15(5): R238.
